Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Verge .....
Good points .......
and I agree 100% ......
she could have ended on a higher note .....
and yes some "MURKY" Questions .......
BUT WE DID RECIEVE BIZ CARDS --- GEO
Ok .....
Now what was the finacing about? ......
What is Richard up to now .......
so far so good using Dutchess ......
no reason to think otherwise ......
INCREASE SHARE HOLDER VALUE? --- GEO
ALSO ......
when you are able to review ......
her performance ......
check out ......
minute 23 ......
which talks about products .......
in Q1 2006 ........
OVER THE POND WE GO, HI HO --- GEO
I counted ......
Three cards .....
given to her as she left the microphone .....
maybe more during the lunch break ........
There is interest ........
she was a little nervous at first .....
but really started to roll .......
LETS FACE IT WE ARE THE FUTURE OF MEDICINE --- GEO
P.S WAY UNDERVALUED ....
Sounds like she is going over her notes ........
KNOCK EM DEAD BARBARA --- GEO
Golf4uto .....
Logged in ...
and I have Butterflies .....
SUPRISE --- GEO
EXCELLENT POST IFADA .... TY ....EOM
StinkBOY .....
Not yet ....... correct ....
But Why wouldn't you join up ......
FASTER, CHEAPER results .......
Lower initial costs to Pharma ........
6yrs of ANCESTRY DATA .......
Personal medicine WILL be based on HERITAGE ......
WE ARE READY, LOCK AND LOAD PAL .......
WE are going to SPIN HEADS ......
in the next 2 weeks .......
STARTING TODAY --- GEO
And Today .....
NOV 30 .......
We should close the deal ....
Acquiring Ellipsis Biotherapeutics .....
and will act as a SUBSIDIARY .....
Of DNAPrint genomics ......
MANY PATENTS, MORE POSSIBLE MONIES ...... GEO
"It is old news, but there is nothing else the matter with it." --- GEO
OK 2002 .....
BUT we have recieved the PATENT ......
and the NR .......
states .....
how FAST as well as CHEAP .......
we can perform the tasks .....
LAST PARAGRAPH STATES: ......
DNAPrint intends to partner this new platform with biotech, pharma and academia seeking to identify new drug targets and diagnostic tests. Using this model, partners would fund the work and the Company would retain a share of the intellectual property produced. DNAPrint hopes to use the method with partners to discover hundreds or even thousands of disease genes and to acquire a significant stake in the future of genomics-based medicine. Given the magnitude of drug and diagnostics royalties, relatively few of the discovered genes need be developed as drug targets or diagnostic tests to render the endeavor a success.
ARE YOU GUYS NOT CLUEING IN, OR JUST PLAYING GAMES --- GEO
Mikefl ......
I don't really know ......
what year it was written ......
but the important thing .....
to keep in mind ......
and this was my POINT .....
we have recieved a PATENT ......
just lately on ADMIXMAP .......
Very important ......
when it comes to "courting" big pharma .....
GO BARBARA GO --- GEO
Represents an important milestone in human genome research
DNAPrint Launches Revolutionary Pan-Genome Screening Platform Based on Ancestral Admixture Mapping
Monday December 9, 11:18 am ET
SARASOTA, Fla., Dec. 9 /PRNewswire/ -- DNAPrint genomics, Inc. (OTC Bulletin Board: DNAP - News; the "Company"), unveiled a new whole-genome screening platform (ADMIXMAP) that promises to rapidly change the landscape of disease and drug response gene hunting. The new platform is revolutionary because it represents the first yet developed for cost-effective whole-genome scanning in large, heterogeneous populations. It taps into sequence differences among the world's various continental population groups to increase the power and efficiency of pan-genome disease gene screening.
ADMIXMAP will allow DNAPrint to identify new disease and drug response genes 10 times faster and 1,000-times less expensively than others who use existing methods. Dr. Tony Frudakis, CEO, informally announced the introduction of ADMIXMAP to attendees at the invitation-only IBM Life Science Solution Developer Conference in Boca Raton, FL, and proclaimed the Company's intent to partner collaborative services based on the platform to pharma, biotech and academia.
The development of ADMIXMAP was a culmination of years of research into population genomics structure and human ancestry conducted with Dr. Mark Shriver of the Pennsylvania State University. The primary focus of the work was to create an original type of human genome map based on validated and characterized Ancestry Informative Markers. snAIMs are Single Nucleotide Polymorphsims (SNPs) of significant allele frequency differences between the world's various continental population groups; prior to DNAPrint's work, such a map had not existed. This map is combined with other compositions and new, highly specialized analytical algorithms to constitute the ADMIXMAP platform. The platform functions by allowing a fine appreciation of population genomics structure relevant for solving complex human conditions, and it is based on a process called Mapping by Admixture Linkage Disequilibrium (MALD) or Admixture Mapping (AM).
DNA exists in a block like state, and hypothesis-free genome screens aim to inspect each of several hundred thousand of these blocks for sequence correlation with disease or drug response. A genome-wide study usually queries hundreds of genomes. Because each genotype costs about $0.50 and hundreds of thousands of genotypes need be created per genome, a typical genome study costs several tens of millions of dollars.
On the other hand, Mapping by Admixture Linkage Disequilibrium (MALD) or Admixture Mapping (AM) takes advantage of the fact that in recently admixed populations (i.e. Hispanics or African Americans, among many others), the block-like structure of DNA extends for MegaBases rather than kilobases (Chakraborty and Weiss, 1988; Stephens et al., 1994, McKeigue 1998, McKeigue et al., 2000). Because the DNA is made of a relatively small number of very large blocks, pan-genome coverage can be obtained with as few as 1,500 markers at a cost of only $1-2K per sample or a couple hundred thousand dollars per study.
MALD and AM can only be accomplished using Ancestry Informative Markers (AIMs) and to its knowledge, the Company is the only to yet mine the human genome to produce a pan-genome map of validated snAIMs. In addition to a validated AIM map, the MALD/AM methods also require the determination of individual ancestry admixture proportions and DNAPrint was the first to reduce the determination of individual admixture proportions using AIMs to commercial practice (see www.ancestrybydna.com). As a result, DNAPrint believes it is the only company in the world capable of practicing the MALD and AM methods.
"The single largest problem drug and diagnostics developers currently face is the cost associated with genotyping," said Dr. Matt Thomas, DNAPrint's Chief Molecular Biologist. "Due to this cost, most whole-genome research today is restricted to isolated, homogeneous populations, which can limit the general applicability of the results obtained."
"In part, the human genome was sequenced to help us get away from a restrictive focus on homogeneous, isolated populations for drug and diagnostics design," said Zack Gaskin, DNAPrint's Chief Technician. "Because ADMIXMAP is the first platform to enable cost-effective whole genome scans in heterogeneous populations, we expect it to have a profound impact on genomics- based drug and diagnostics design and we consider its development to represent an important milestone in human genome research."
DNAPrint intends to partner this new platform with biotech, pharma and academia seeking to identify new drug targets and diagnostic tests. Using this model, partners would fund the work and the Company would retain a share of the intellectual property produced. DNAPrint hopes to use the method with partners to discover hundreds or even thousands of disease genes and to acquire a significant stake in the future of genomics-based medicine. Given the magnitude of drug and diagnostics royalties, relatively few of the discovered genes need be developed as drug targets or diagnostic tests to render the endeavor a success.
LAST PARAGRAPH VERY, VERY IMPORTANT --- GEO
Jeepers00 ......
Am I to think that this is ......
I'll get right back to you? ........
CRIPES HE'S RIGHT? --- GEO
money4nothin .......
The joker is thrown away .....
the joker is not WILD .....
the joker is not an advantage .......
Do your DD ......
Understand the POSSIBLE outcome if you "HIT" ......
DNAG is on the move ......
The K report told us the Worth of what we are holding ......
percentage wise we are in "great shape" ......
believe what you see and not what your hear .........
DON'T listen to anyone but yourself .........
YOUR DD IS YOUR "POCKET BULLETS" --- GEO
Poker? .......
Ok I liked the Poker idea .....
and how it mirrors this BB ......
so here we go .......
Look at your cards ......
play your cards .......
make your bet .......
stand on your bet ......
wait to see the next draw ......
VERY IMPORTANT .......
wait for your NEXT CARDS .......
do NOT be STARED DOWN .......
know the possible advantage of your hand ........
Play your hand after the LAST DRAW ........
LETS SEE THE RIVER CARD --- GEO
Jeepers00 .....
OK .....
Make it a "good puzzle" though ......
But still a CRIPES HE WAS RIGHT .....
Thank You --- GEO
thtideisturning ......
Shouldn't it be capitized ......
Genomics --- GEO
Jeepers00 ......
OK lets pretend ......
that you know something we don't ......
Like sayyyyyyyyy .....
"something" is complete ......
Now when illwill threw us a bone .....
he would at least give ......
HOLD YOUR BUTZZZZZ ....
maybe even a hint ........
so lets say you give us a hint .....
with out actually "telling" us .......
something were we can look back and say ......
CRIPES he was right .......
personally I have never bought on your recomendations .....
PROVE ME WRONG --- GEO
Money4nothin .....
in response to you ......
How can you have any pudding .....
if you don't eat your meat? ......
ANOTHER BRICK IN "MY" WALL --- GEO
wrl
You foul mouth basher you ....
can you tell me why we went .....
to dutchess .....
can you tell me why .......
we needed the funds .......
I bet you will be able to tell me ....
LATER --- GEO
Michiko ......
I loved your post .......
BUT HEY .....LOL --- GEO
Just a little bit of News ...
NEW YORK, Nov 29, 2005 (BUSINESS WIRE) -- The New York Society of Security Analysts (NYSSA) will present the 9th Annual Biotech/Specialty Pharma Conference on December 14 to 15, 2005.
Positive news from drug companies and a strengthening economy have given biotech and specialty pharma stocks a respectable year thus far. What does the future have in store for some of the industry's fastest-growing small cap drug companies? Learn where the investment opportunities are in these developing sectors.
The following companies are presenting on day one:
Advancis Pharmaceutical Corp. (AVNC); Bionovo, Inc. (OTCBB: NBVI); BioSante Pharmaceuticals, Inc. (BPA); Celsion Corporation (CLN); Depomed, Inc. (DEPO); DNAPrint genomics, Inc. (DNAG); DURECT Corporation (DRRX); Elite Pharmaceuticals, Inc. (ELI); Exact Sciences (EXAS); Matritech, Inc. (MZT); and Valentis, Inc. (VLTS).
The following companies are presenting on day two:
Aethlon Medical, Inc. (AEMD); Bioenvision (BIVN); Commonwealth Biotechnologies, Inc. (CBTE); Hemispherx Biopharma, Inc. (HEB); NovaDel Pharma Inc. (NVD); Peregrine Pharmaceuticals, Inc. (PPHM); SIGA Technologies, Inc. (SIGA); and Zonagen, Inc. (ZONA).
The conference will be held on December 14 to 15, 2005, 8:00 a.m. to 5:00 p.m., at the Harvard Club, 27 West 44th Street, New York, NY. Early registration by November 30 one day, $195 NYSSA members, $295 nonmembers; two days, $295 NYSSA members, $395 nonmembers. Prices $70 higher after November 30. Registration deadline is December 7. No charge for press with credentials. A complete agenda is available at http://www.nyssa.org/Template.cfm?Section=calendar&template=/ ContentManagement/ContentDisplay.cfm&ContentID=6289 (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)
About NYSSA
NYSSA, established in 1937, is the premier independent forum for the exchange of information among investment decision-makers. A not-for-profit educational organization with over 9,000 members, NYSSA is committed to the promotion of best practices and the highest professional and ethical standards in the investment industry. NYSSA is the largest of the more than 131 societies worldwide that make up CFA Institute, which has more than 70,000 members.
SOURCE: The New York Society of Security Analysts
MOVIN MOVIN MOVIN --- GEO
Dr FUD ......
I'm in ......
if you are keeping track .......
The Dump, The Catch .......
THANK YOU --- GEO
Thought for the day ....
"Life belongs to the living, and he who lives must be prepared for changes."
- Johann Wolfgang von Goethe
Dr FUD ......
Lets see .....
where will we end up today? .....
you ask .......
Lets see ......
Million dollar , No , No Billion dollar ......
Revenue Generator ......
Starting to close into 2006 ......
I would say we should be HIGHER today ......
But I have said it time and time again ......
we are UNDER VALUED .........
So for a penny or 2 .......
What the Heck I will look for an entry point today .....
or tommorow ......
you Know I like to average down ......
It all comes down to this is the year .....
for Ovanome ......
as well as a possible suprise along the way .......
SO I PREDICT AN UP DAY, HEAVY VOL --- GEO
What a day ......
Sorry I missed it ......
After looking at todays trades .......
The DUMP was on .......
To bad ......
But on the other hand .......
and this is important ........
Very few shares traded at the END of the day ......
Average down? .......
HOLD AND BUY THE DEALS ........
We are going to be a million dollor Co . .......
and by the "TIME FRAME and EXPECTED REVENUE" ......
A billion dollar Co .......
Todays NR from Merck was VERY INTERESTING ......
Cutting back on their R&D? ............
They must feel it would be more benificial .......
to contract the Work out .......
We have ADMIXMAP .......
we have an awesome R&D TEAM .......
We have 18% BIOFRONTERA .......
we have EXPECTED REVENUES .......
we have So many products to come on line ........
If you can ADD ADD ADD ........
increase your position .......
Strength in numbers? .......
PERHAPS WE WILL SEE SOME NUMBERS .......
GO LONG AND HOLD ........
holding is very important ........
We are way under valued ........
HOLD THE LINE --- GEO
DNAG ......
Their Story has to get out ......
Investors have to be involved .......
The more knowledgeable investor the better .......
This Science can not be "trashed" by BASHERS .....
Who have an unseen agenda .......
There is POWER in numbers .......
WE ARE WAY UNDER VALUED --- GEO
P.S SOOOOOOO MUCH MONEY ....
dr fud ....
YOU MAKE ME LAUGH --- GEO
Merck to cut 7,000 jobs as part of a restructuring effort, Reuters reports
RESTRUCTURING? --- GEO
golf4uto....
thought that offering was the 20 million euro bond that commenced in september... yes/no??
yes ....
Igot ahead of myself, sorry .......
I knew that ......
The rest of your Question .......
I am not a Swing trader .....
so I can't help you .......
I just plan on holding my position and buying on weakness ....
Long term this is my plan ........
I am acting as SUPPORT ......
Profits will be taken I'm sure .......
But we are In a BULL cycle ........
and something is up ......
unless investors are noticeing the potential .....
of DNAG .......
Richard is building an R&D TEAM .......
That rivals many BIG PHARMAs ........
plus we have our own PRODUCTS ........
that will generate millions if not billions .....
over time ........
I plan to ride this elevator .......
right to the TOP ......
it may stop on many floors ......
but I'm PRESSING "P" ......
FOR PENTHOUSE ... LOL --- GEO
Any Comments? ....
On July 8, 2005, the Registrant entered into an agreement to purchase, and
simultaneously closed upon the purchase of, an 18% equity interest in
Biofrontera AG ("Biofrontera"), a German company in the pharmaceutical business.
The Registrant purchased the interest in Biofrontera from
Technologie-Beteiligungs-Gesellschaft mbH, an instrumentality of the German
government. The securities purchased were shares of Biofrontera's series A
Preferred Stock, as well as certain debt instruments.
The Registrant paid (euro)1.5 million (approximately $1.84 million) for
the interest in Biofrontera. In connection with the transaction, two of the
members of the registrant's Board of Directors, Richard Gabriel and Hector
Gomez, were retained on the Biofrontera board.
In addition, to induce the shareholders of Biofrontera to consent to the
transaction, the Registrant entered into a put agreement with another
Biofrontera shareholder, Heidelberg Innovation. Pursuant to this agreement, if
by December 31, 2005 Biofrontera does not complete its current offering of debt
securities for at least (euro)10 million, Heidelberg Innovation may require the
Registrant to purchase Heidelberg Innovation's ownership interest in Biofrontera
of approximately 49% for (euro)1.6 million (approximately $1.96 million).
HAS BIOFRONTERA COMPLETED ITS OFFERING OF DEBT SECURITIES --- GEO
Camptosar .......
By PFIZER ......
read page 4 under "race" ......
actually read the whole thing "very interesting" ....
Heritage is mentioned ..... (ANCESTRY)
may explain why PFIZER was mentioned in the K report .....
and may lead "one" to think of the top 50 Company .....
http://www.pfizer.com/pfizer/download/uspi_camptosar.pdf
JMHO but VERY INTERESTING --- GEO
Hmmmmm .....
In March, the F.D.A. issued guidelines to encourage drug companies to pursue personalized medicine, and the agency is adding information about genetic tests to the labels of a few drugs.
Since June, the label for Camptosar, a Pfizer drug for colon cancer, has advised doctors that a lower starting dose may be appropriate for the 10 percent of people who have a particular version of a gene called UGT1A1. The variant makes them more prone to a side effect, serious decline in white blood cells
PFANTASTIC --- GEO
What seperates us from the others?
At the last ASCPT meeting, Perlegen presented reports on Taxol/Carboplatin with well over 1,000 samples. They were not able to make heads or tails of their data. They were not able to predict responders or non-responders. At the same conference, we presented similar Taxol/carbo data with our first go around of 80 patients, where we had 96 % sensitivity and 95 % specificity for the test that predicts responders and non-responders. So that is proof to the point. That’s what separates us from the competition.
MILLIONS NO, NO, BILLIONS --- GEO
Just kidding .....
Anybody else .....
haveing problems .....
with their Space helmet .....
Fogging UP .....lol
DNAG NEEDS TO BE ON ANOTHER BOARD --- GEO
Easyman ......
The SP has been DRIVEN down on LOW VOL ......
it was JMHO that it was submersive attempt ......
to accumulate shares at "CHEAP" prices ......
although DNAG can not control this ......
WE as LONGS have had to "CRINGE" as this happened .......
JUST LOOK AT THE CHARTS .........
Well now we have a "TIME LINE and FUTURE REVENUE" ...........
Time schedule ..........
We have "FACTS and FIGURES" ..........
Something we didn't have before .........
Cripes! we even have "products" we didn't even know we had ...
I am more impressed thn I was before .....
and before I was VERY impressed ......
I don't care what we do MONDAY or TUESDAY or any other day ....
We will go UP and DOWN .......
but I really believe LONG TERM we are UP UP and AWAY! .....
sooo RAH RAH RAH .....
or invert it to HAR HAR ......
I don't really care SHORT TERM .....
ITS LONG TERM I am in for .......
So GO! SHORTS, GO! LONGS, GO! EVERYBODY ........
but most of all .......
GO! TO EVERYONE WHO CAN BENIFIET FROM THE SCIENCE --- GEO
Nickoftime .....
To say you are long .....
and question EASYMAN51? .....
Lets just say,/////////////////////// you showed up! .......
and have not participated in the "debate" trench of Warfare ....
DNAG BB has been a place of RIGHT vs WRONG ........
WAR OF THE WORDS, right here DAY in DAY OUT .....
You have nothing .......
nothing, that has been fought over tooth and nail, about DNAG ....
So you ask what of the RAH RAH? ......
Many here have defended DNAG .....
saw our investment dollars dwindle on low VOL ......
but held on to our shares because we believed in DNAG ....
some even averaged down .......
We have spent a lot of "TIME and MONEY" on defence ......
soooooo why the RAH RAH? ........
simple ......
we now have the BALL .....
WE ARE ON THE OFFENCE --- GEO RAH RAH RAH
IT'S THE END OF THE WORLD ........
Started reading the IHUB board this morning .......
thought I was haveing a dream ......
The BASHERS are "just now" seeing the light?.....
The "second comeing" was for told .......
ILLWILL IS BACK .......
The "meek" shall inherit the earth .......
and for US? what of US?
Day in Day out defending the GOOD name of DNAG ......
ITS THE END OF THE WORLD AS WE KNOW IT ........
AND I FEEL FINE --- GEO
illwill ......
GREAT to see you again .....
DNAG is on the move ......
HOLY MOLY YOUR BACK, I'M PLEASED --- GEO